About
QuantaMatrix Inc. is a South Korean in-vitro diagnostics company founded in 2010, originating from the Biophotonics and Nano Engineering Lab at Seoul National University. The company specializes in clinical microbiology diagnostics, particularly in rapid antimicrobial susceptibility testing, to enhance patient outcomes and address antimicrobial resistance. Headquartered in Seoul, QuantaMatrix develops innovative diagnostic solutions for infectious diseases. Their key products include dRAST, a rapid test for sepsis that significantly shortens the time to effective antimicrobial therapy, and QDST, which aids in faster tuberculosis treatment decisions. They also offer the QPLEX Alz plus assay for early Alzheimer's detection and prognostic kits for cardiovascular diseases, currently for research use. QuantaMatrix's products are available in South Korea, Europe, and the Middle East, targeting clinical laboratories and healthcare providers. The company is committed to expanding globally, including plans to enter the US market, to improve clinical outcomes and tackle the challenge of antimicrobial resistance. Their solutions have received notable certifications, highlighting their innovation and clinical significance.
Technologies
Keywords
Company Information
-
Employees 69
-
Founded 2010
-
Annual Revenue $1551000
Location
Seoul, South Korea, 08826
